U.S.–U.K. Alliance Targets World’s Deadliest Superbugs Posted on March 31, 2017 at 12:14 am.Written by Spero Therapeutics Post navigation AMPs take aim at AMRs as biopharma seeks new solutions to resistanceCARB-X’s first round of grants goes to firms big and small in antimicrobial resistance fight
